Literature DB >> 12526978

A new treatment for HCV-ulcerative colitis comorbidity intolerant to INF-alpha.

Koji Sawada, Kunio Ohnishi, Ken Fukunaga, Takashi Shimoyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12526978     DOI： 10.1111/j.1572-0241.2003.07193.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

Review 1.  The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.

Authors:  H Hanai; Y Takeda; M Eberhardson; R Gruber; A R Saniabadi; O Winqvist; R Lofberg
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

2.  Dramatic response to granulocytapheresis in a Crohn's disease case complicated by hepatitis C virus.

Authors:  Koji Sawada; Kunio Ohnishi; Takeshi Kusaka; Yoshika Matoba; Ken Fukunaga
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

Authors:  Alina M Allen; W Ray Kim; Joseph Larson; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

4.  Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report.

Authors:  Yuki Ohta; Tatsuo Kanda; Tatsuro Katsuno; Shin Yasui; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Makoto Arai; Osamu Yokosuka
Journal:  BMC Gastroenterol       Date:  2016-07-11       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.